SequelSEC

MiniMed Group, Inc. MMED

Surgical & Medical Instruments & Apparatus · CIK 0002062583 · Fiscal year ends 1231

AnnualQuarterlyTTM
Revenue
$843.00M
Fiscal year ended 2026-07-31
Operating income
$5.00M
Fiscal year ended 2026-07-31
Free cash flow
-$90.00M
Fiscal year ended 2026-07-31

MiniMed Group, Inc. (MMED) reported revenue of $843.00M and net income of $0 for the fiscal year ended 2026-07-31. This page shows 7 annual periods of income statement, balance sheet and cash flow figures normalized from MiniMed Group, Inc.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Surgical & Medical Instruments & Apparatus.

Income

MiniMed Group, Inc. income by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-07-312026-04-242026-01-232025-07-252025-04-252025-01-242024-04-26
Revenue$843.00M$837.00M$790.00M$723.00M$724.00M$687.00MUnavailable
Cost of revenue$378.00M$357.00M$428.00M$314.00M$318.00M$292.00MUnavailable
Gross profit$465.00M$480.00M$362.00M$409.00M$405.00M$395.00MUnavailable
Operating income$5.00M-$93.00M-$100.00M-$13.00M-$148.00M$21.00MUnavailable
Net income$0-$185.00M-$119.00M-$19.00M-$172.00M-$10.00MUnavailable
Research & developmentUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Weighted-average diluted sharesshares 281.00MUnavailableshares 252.81Mshares 252.80MUnavailableshares 252.81MUnavailable
Pretax income$4.00M-$92.00M-$99.00M-$13.00M-$148.00M$21.00MUnavailable
Income tax expense$4.00M$93.00M$12.00M$3.00M$21.00M$28.00MUnavailable
Diluted EPS$0.00Unavailable$-0.47$-0.08Unavailable$-0.04Unavailable
Selling, general & administrative$312.00M$299.00M$309.00M$283.00M$276.00M$268.00MUnavailable
General & administrativeUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Selling & marketingUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable

Balance

MiniMed Group, Inc. balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-07-312026-04-242026-01-232025-07-252025-04-252025-01-242024-04-26
Cash & equivalents$207.00M$298.00M$10.00MUnavailable$11.00MUnavailableUnavailable
Total assets$4.72B$4.63B$4.34BUnavailable$4.20BUnavailableUnavailable
Current assets$1.42B$1.35B$1.11BUnavailable$939.00MUnavailableUnavailable
Total liabilities$1.10B$1.02B$881.00MUnavailable$871.00MUnavailableUnavailable
Current liabilities$782.00M$702.00M$696.00MUnavailable$710.00MUnavailableUnavailable
Total equity incl. NCI$3.62B$3.61B$3.46B$3.54B$3.33B$3.48B$3.45B
Temporary (mezzanine) equityUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Inventory$356.00M$341.00M$408.00MUnavailable$311.00MUnavailableUnavailable
Accounts receivable$180.00M$200.00M$653.00MUnavailable$570.00MUnavailableUnavailable
Goodwill$2.26B$2.26B$2.26BUnavailable$2.26BUnavailableUnavailable
Long-term debtUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Accounts payable$251.00M$163.00M$303.00MUnavailable$205.00MUnavailableUnavailable

Cash flow

MiniMed Group, Inc. cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-07-312026-04-242026-01-232025-07-252025-04-252025-01-242024-04-26
Operating cash flow-$49.00M-$170.00M$114.00M-$141.00M$83.00MUnavailableUnavailable
Capital expenditures$41.00M$56.00M$114.00M$53.00M$57.00MUnavailableUnavailable
Investing cash flow-$41.00M-$56.00M-$114.00M-$63.00M-$57.00MUnavailableUnavailable
Financing cash flow$0$512.00M$2.00M$202.00M-$25.00MUnavailableUnavailable
Net change in cash-$91.00M$287.00M$2.00M-$2.00M$1.00MUnavailableUnavailable
Stock-based compensation$10.00M$8.00M$29.00M$9.00M$9.00MUnavailableUnavailable
Common dividends paidUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Common share repurchasesUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Depreciation & amortization$41.00M$39.00M$78.00M$39.00M$38.00MUnavailableUnavailable

Derived

MiniMed Group, Inc. derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-07-312026-04-242026-01-232025-07-252025-04-252025-01-242024-04-26
Free cash flow-$90.00M-$226.00M$0-$194.00M$26.00MUnavailableUnavailable
Gross margin55.2%57.3%45.8%56.6%55.9%57.5%Unavailable
Operating margin0.6%-11.1%-12.7%-1.8%-20.4%3.1%Unavailable
FCF margin-10.7%-27.0%0.0%-26.8%3.6%UnavailableUnavailable
SBC / revenue1.2%1.0%3.7%1.2%1.2%UnavailableUnavailable
Current ratio1.81x1.92x1.59xUnavailable1.32xUnavailableUnavailable
Revenue YoY growth16.6%15.6%15.0%UnavailableUnavailableUnavailableUnavailable
Net margin0.0%-22.1%-15.1%-2.6%-23.8%-1.5%Unavailable
R&D / revenueUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
CapEx / revenue4.9%6.7%14.4%7.3%7.9%UnavailableUnavailable
Long-term debt / equityUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Effective tax rate100.0%UnavailableUnavailableUnavailableUnavailable133.3%Unavailable

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open MMED in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-09-08View SEC filing
10-K · Filed 2026-06-29View SEC filing
10-Q · Filed 2026-04-17View SEC filing

Companies in the same industry

ADGM AEMD ALUR AMIX ANGO ANIK AORT APYX ARAY ATEC ATRC AURX

Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.